2022
DOI: 10.1016/j.jddst.2022.103303
|View full text |Cite
|
Sign up to set email alerts
|

Amine as a bottom-line functionality on DDS surface for efficient endosomal escape and further subcellular targets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 54 publications
0
3
0
Order By: Relevance
“…Tertiary amines have a strong proton absorption capacity in the inner body (pH, 5–6) and lysosomes (pH, 4–5), leading to rapid osmotic expansion and mRNA release [ 22 ]. The high transfection efficiencies of Cp1-4 , Cp1-5 , Cp1-6 and Cp1-7 may be related to this.…”
Section: Resultsmentioning
confidence: 99%
“…Tertiary amines have a strong proton absorption capacity in the inner body (pH, 5–6) and lysosomes (pH, 4–5), leading to rapid osmotic expansion and mRNA release [ 22 ]. The high transfection efficiencies of Cp1-4 , Cp1-5 , Cp1-6 and Cp1-7 may be related to this.…”
Section: Resultsmentioning
confidence: 99%
“…There are three common approaches to overcome this issue. In the first approach, nanoparticle surface chemistry is designed for endosomal escape. In this case, the nanoparticle surface is functionalized with primary/secondary/tertiary amines, which offers a proton-sponge effect so that the endosome will swell followed by the release of the nanoparticle. In some cases nanoparticles are designed in such a way that its chemical changes inside the endosomal compartment can lead to endosomal escape . The second approach involves liposome-based direct cell translocation via cell membrane fusion. In these processes, liposome interacts with the cell membrane and opens a temporary pore for the drug release.…”
Section: Introductionmentioning
confidence: 99%
“…Targeted delivery of DDSs occurs via three-tier distribution levels to reach its intended site of action, involving specific tissue, individual cells, and finally, intracellular organelles to exhibit their pharmacological activities following a particular mechanism of action. Fascinatingly, the nucleus has gained significant interest as the primary organelle for tumor-targeted drug delivery. , The nucleus serves as the control center of eukaryotic cells, which stores and replicates genetic material, modulates transcription and ribosome assembly, and controls protein synthesis. To achieve efficient therapeutic efficacy, the anticancer drugs must successfully permeate the target cell via the cell membrane and reach the nucleus, thereby enhancing the effectiveness and efficacy of drug treatment. Various anticancer drugs engage with nuclear DNA and related enzymes, inhibiting DNA replication and inducing cell death.…”
Section: Introductionmentioning
confidence: 99%